| Literature DB >> 32429846 |
Chun Yang1, Xiu Han2, Yuan Du1, Ai-Qun Ma1.
Abstract
BACKGROUND: Takotsubo cardiomyopathy (TTC) has been widely recognized in recent decades and is triggered by either physical or psychological stressors. CASEEntities:
Keywords: Hypopituitarism; Pituitary apoplexy; Stress cardiomyopathy; Takotsubo; Takotsubo cardiomyopathy
Year: 2020 PMID: 32429846 PMCID: PMC7236106 DOI: 10.1186/s12872-020-01521-1
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Fig. 1Pituitary CT at trauma 6 months ago showing subarachnoid and left subdural haemorrhage (Fig. 1a) and pituitary microadenoma (Fig. 1b)
Laboratory tests-pituitary function
| Paraclinical tests | Value | Reference value |
|---|---|---|
| Thyroid hormone | ||
| Thyrotropin (TSH) | 0.414 μIU/mL | 0.25–5 μIU/mL |
| Thyroxine (T4) | 2.22 μg/dL | 4.2–13.5 μg/dL |
| Triiodothyrosine (T3) | 0.550 ng/ml | 0.8–2.2 ng/ml |
| Free-T4 (FT4) | 4.98 pmol/L | 9.05–25.5 pmol/L |
| Free-T3 (FT3) | 3.19 pmol/L | 2.91–9.08 pmol/L |
| Sex hormone | ||
| Luteinizing hormone (LH) | < 0.1 mIU/mL | 7.7–58.5 mIU/mL |
| Follicle-stimulating hormone (FSH) | 0.927 mIU/mL | 25.8–134.8 mIU/mL |
| Pituitary prolactin (PRL) | 0.24 ng/ml | 4.79–23.3 ng/ml |
| Oestradiol (E2) | < 18.4 pmol/L | < 18.4–201 pmol/L |
| Progesterone (P) | 0.16 nmol/L | 0.3–2.5 nmol/L |
| Testosterone (T) | < 0.087 nmol/L | 0.101–1.42 nmol/L |
| Adrenal hormone | ||
| Adrenocorticotropic hormone (ACTH) | < 1.0 pg/ml | 7.2–63.3 pg/ml |
| COR | 4.6 μg/dl | 5.0–28.0 μg/dl |
Fig. 2Pituitary MRI at admission showed an enlarged pituitary gland with heterogenous high signal on coronal T2 weighted image (Fig. 2a) and central low signal with peripheral rim enhancement on post contrast T1 weighted coronal (Fig. 2b) and sagittal (Fig. 2c) images causing mild compression on the optic chiasm, which is suggestive of acute pituitary apoplexy
Laboratory tests-cardiac function
| Paraclinical tests | Value | Reference value |
|---|---|---|
| Brain natriuretic peptide (Pro-BNP) | 0–125 pg/ml | |
| 2018-01-06 | 3069 pg/ml | |
| 2018-01-09 | 3037 pg/ml | |
| 2018-01-12 | 6178 pg/ml | |
| 2018-01-19 | 500.8 pg/ml | |
| C reactive protein (CRP) | 11.1 mg/L | 0–10 mg/L |
| Hypersensitive C reactive protein (hs-CRP) | > 10 mg/L | 0–3 mg/L |
| Troponin T (cTnT) | 0–0.014 ng/ml | |
| 2018-01-06 | 0.046 ng/ml | |
| 2018-01-12 | 0.010 ng/ml |
Fig. 3a ECG at admission showing T-wave inversion on the inferior and anterior wall and extended QT interval. b ECG at 10 days after treatment, showing that T-wave inversion partially recovered and QT interval returned to normal
Fig. 4a b c Four-chamber view of TTE at admission showing ventricular “ballooning” caused by apical dyskinesis. d Four-chamber view of TTE at 7 days after treatment showing that LV apical “ballooning” was recovered. e f Four-chamber view of TTE two months later, showing no LV apical “ballooning” or wall motion abnormalities
Fig. 5CAG demonstrating no significant coronary obstructive stenosis (both right and left coronary were nomal)
Fig. 6Left ventricular angiogram demonstrating that the LV had a peculiar shape (a round bottom and narrow neck), which resembles the type of bottle used in Japan for trapping octopus